Alvotech (ALVO) stock
ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW
$4.55+0.18 (+4.12%)
Close on Nov 18, 2026Market cap $1.42BP/E 45.5Yield –
Alvotech revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was $586.32M, up 19.7% from the year before. The highest annual figure on record is $586.32M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $586.32M | +19.7% |
| FY2024 | Dec 31, 2024 | $489.68M | +435.6% |
| FY2023 | Dec 31, 2023 | $91.43M | +10.1% |
| FY2022 | Dec 31, 2022 | $83.03M | +125.8% |
| FY2021 | Dec 31, 2021 | $36.77M | -44.8% |
| FY2020 | Dec 31, 2020 | $66.62M | – |
See a number that looks wrong?